• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.66% Nasdaq Down1.05%

    Simulations Plus, Inc. (SLP)

    -NasdaqCM
    7.22 Down 0.07(1.02%) Sep 4, 3:59PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Simulations Plus, Inc.
    42505 Tenth Street West
    Lancaster, CA 93534
    United States - Map
    Phone: 661-723-7723
    Fax: 661-723-5524
    Website: http://www.simulations-plus.com

    Details 
    Index Membership:N/A
    Sector:Technology
    Industry:Business Software & Services
    Full Time Employees:66

    Business Summary 

    Simulations Plus, Inc. designs and develops pharmaceutical simulation software for use in pharmaceutical research, and in the education of pharmacy and medical students. Its products include GastroPlus that simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs administered to humans and animals; DDDPlus, which simulates in vitro laboratory experiments to measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus that simulates laboratory experiments. The company also offers ADMET Predictor, a computer program that takes molecular structures as inputs and predicts their properties; MedChem Studio, a tool for data mining and designing new molecules; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor. In addition, it is involved in the analysis and reporting of data collected during clinical trials of new and existing pharmaceutical products; and provision of consulting and contract research services to the pharmaceutical industry. The company operates in North America, South America, Europe, Japan, Australia, New Zealand, India, Singapore, and the People’s Republic of China. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Simulations Plus, Inc.

    Key Executives 
     PayExercised
    Mr. Walter S. Woltosz , 70
    Co-Founder, Chairman and Chief Exec. Officer
    342.00K0.00
    Mrs. Virginia E. Woltosz , 64
    Co-Founder, Treasurer and Sec.
    60.00K0.00
    Mr. John R. Kneisel CPA, 57
    Chief Financial Officer
    120.00K0.00
    Mr. John Anthony DiBella M.S., 35
    VP of Marketing and Sales
    192.00K0.00
    Dr. Thaddeus Henry Grasela Jr., PharmD, Ph.D., 61
    Pres and Director
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders